share_log

Market-Moving News for February 1st

Market-Moving News for February 1st

2月1日的市場動向新聞
Benzinga ·  02/01 08:35

NRBO: 103% | NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity

NRBO:103% | NeuroBo Pharmaceuticals 宣佈 FDA 批准用於治療肥胖的 DA-1726 的 1 期臨床試驗

AUVI: 28% | EXCLUSIVE: Applied UV Tells Benzinga 'We estimate that potential revenues from this project could total $250 Million to $300 Million over the next 3 to 6 years'

AUVI:28% | 獨家:應用紫外線告訴本辛加:“我們估計,未來3到6年,該項目的潛在收入總額可能達到2.5億至3億美元

GOOS: 12% | Canada Goose Hldgs Q3 2024 Adj EPS C$1.37, Inline, Sales C$609.90M Miss C$620.05M Estimate

GOOS:12% | 加拿大鵝控股公司2024年第三季度調整後每股收益1.37加元,聯機,銷售額爲6.099億加元,低於6.205億加元的預期

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論